These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22821403)

  • 21. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
    Melum E; Franke A; Schramm C; Weismüller TJ; Gotthardt DN; Offner FA; Juran BD; Laerdahl JK; Labi V; Björnsson E; Weersma RK; Henckaerts L; Teufel A; Rust C; Ellinghaus E; Balschun T; Boberg KM; Ellinghaus D; Bergquist A; Sauer P; Ryu E; Hov JR; Wedemeyer J; Lindkvist B; Wittig M; Porte RJ; Holm K; Gieger C; Wichmann HE; Stokkers P; Ponsioen CY; Runz H; Stiehl A; Wijmenga C; Sterneck M; Vermeire S; Beuers U; Villunger A; Schrumpf E; Lazaridis KN; Manns MP; Schreiber S; Karlsen TH
    Nat Genet; 2011 Jan; 43(1):17-9. PubMed ID: 21151127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases.
    Yu X; Wieczorek S; Franke A; Yin H; Pierer M; Sina C; Karlsen TH; Boberg KM; Bergquist A; Kunz M; Witte T; Gross WL; Epplen JT; Alarcón-Riquelme ME; Schreiber S; Ibrahim SM
    Genes Immun; 2009 Sep; 10(6):601-5. PubMed ID: 19387457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide association study of ulcerative colitis in Koreans suggests extensive overlapping of genetic susceptibility with Caucasians.
    Yang SK; Hong M; Zhao W; Jung Y; Tayebi N; Ye BD; Kim KJ; Park SH; Lee I; Shin HD; Cheong HS; Kim LH; Kim HJ; Jung SA; Kang D; Youn HS; Liu J; Song K
    Inflamm Bowel Dis; 2013 Apr; 19(5):954-66. PubMed ID: 23511034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
    Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
    Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.
    Kumagai J; Taida T; Ogasawara S; Nakagawa T; Iino Y; Shingyoji A; Ishikawa K; Akizue N; Yamato M; Takahashi K; Ohta Y; Hamanaka S; Okimoto K; Nakamura M; Ohyama H; Saito K; Kusakabe Y; Maruoka D; Yasui S; Matsumura T; Sugiyama H; Sakai Y; Mikata R; Arai M; Katsuno T; Tsuyuguchi T; Kato N
    PLoS One; 2018; 13(12):e0209352. PubMed ID: 30571774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
    Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
    J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.
    de Krijger M; Hageman IL; Li Yim AYF; Verhoeff J; Garcia Vallejo JJ; van Hamersveld PHP; Levin E; Hakvoort TBM; Wildenberg ME; Henneman P; Ponsioen CY; de Jonge WJ
    Front Immunol; 2022; 13():840935. PubMed ID: 35371111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Ten Additional Susceptibility Loci for Ulcerative Colitis Through Immunochip Analysis in Koreans.
    Ye BD; Choi H; Hong M; Yun WJ; Low HQ; Haritunians T; Kim KJ; Park SH; Lee I; Bang SY; Kim TH; Shin HD; Kang D; Youn HS; Li Y; Liu J; McGovern DP; Yang SK; Song K
    Inflamm Bowel Dis; 2016 Jan; 22(1):13-9. PubMed ID: 26398853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
    Głowacki MK; Zwolińska-Wcisło M; Frączek P; Gomulska M; Owczarek D; Cibor D; Cieśla A; Mach T
    Folia Med Cracov; 2015; 55(2):61-8. PubMed ID: 26839244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
    Liu JZ; Hov JR; Folseraas T; Ellinghaus E; Rushbrook SM; Doncheva NT; Andreassen OA; Weersma RK; Weismüller TJ; Eksteen B; Invernizzi P; Hirschfield GM; Gotthardt DN; Pares A; Ellinghaus D; Shah T; Juran BD; Milkiewicz P; Rust C; Schramm C; Müller T; Srivastava B; Dalekos G; Nöthen MM; Herms S; Winkelmann J; Mitrovic M; Braun F; Ponsioen CY; Croucher PJ; Sterneck M; Teufel A; Mason AL; Saarela J; Leppa V; Dorfman R; Alvaro D; Floreani A; Onengut-Gumuscu S; Rich SS; Thompson WK; Schork AJ; Næss S; Thomsen I; Mayr G; König IR; Hveem K; Cleynen I; Gutierrez-Achury J; Ricaño-Ponce I; van Heel D; Björnsson E; Sandford RN; Durie PR; Melum E; Vatn MH; Silverberg MS; Duerr RH; Padyukov L; Brand S; Sans M; Annese V; Achkar JP; Boberg KM; Marschall HU; Chazouillères O; Bowlus CL; Wijmenga C; Schrumpf E; Vermeire S; Albrecht M; ; Rioux JD; Alexander G; Bergquist A; Cho J; Schreiber S; Manns MP; Färkkilä M; Dale AM; Chapman RW; Lazaridis KN; ; Franke A; Anderson CA; Karlsen TH;
    Nat Genet; 2013 Jun; 45(6):670-5. PubMed ID: 23603763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?
    Block M; Jørgensen KK; Oresland T; Lindholm E; Grzyb K; Cvancarova M; Vatn MH; Boberg KM; Börjesson L
    J Crohns Colitis; 2014 May; 8(5):421-30. PubMed ID: 24239402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.
    Pagano E; Elias JE; Schneditz G; Saveljeva S; Holland LM; Borrelli F; Karlsen TH; Kaser A; Kaneider NC
    Gut; 2022 Mar; 71(3):509-520. PubMed ID: 33758004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control.
    Rosa A; Abrantes P; Sousa I; Francisco V; Santos P; Francisco D; Xavier JM; Oliveira SA
    Inflamm Bowel Dis; 2016 Apr; 22(4):774-81. PubMed ID: 26926037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.
    Kempinska-Podhorodecka A; Adamowicz M; Ostrycharz E; Chmielarz M; Wójcicki M; Milkiewicz P; Milkiewicz M
    Sci Rep; 2021 May; 11(1):10134. PubMed ID: 33980925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
    Hov JR; Keitel V; Laerdahl JK; Spomer L; Ellinghaus E; ElSharawy A; Melum E; Boberg KM; Manke T; Balschun T; Schramm C; Bergquist A; Weismüller T; Gotthardt D; Rust C; Henckaerts L; Onnie CM; Weersma RK; Sterneck M; Teufel A; Runz H; Stiehl A; Ponsioen CY; Wijmenga C; Vatn MH; ; Stokkers PC; Vermeire S; Mathew CG; Lie BA; Beuers U; Manns MP; Schreiber S; Schrumpf E; Häussinger D; Franke A; Karlsen TH
    PLoS One; 2010 Aug; 5(8):e12403. PubMed ID: 20811628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for primary sclerosing cholangitis.
    Boonstra K; de Vries EM; van Geloven N; van Erpecum KJ; Spanier M; Poen AC; van Nieuwkerk CM; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; Beuers U; Ponsioen CY;
    Liver Int; 2016 Jan; 36(1):84-91. PubMed ID: 26077553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.